Product image of Metoprolol Alvogen (Metoprolol Succinate) supplied by GNH India

Metoprolol Alvogen

Active Ingredient:
Metoprolol Succinate
Origin:
EU

Metoprolol Alvogen (Metoprolol Succinate)

Metoprolol succinate, the active ingredient in Metoprolol Alvogen, is a beta blocker presented as an oral tablet for oral use. It is employed to treat hypertension, angina pectoris, chronic heart failure, and to provide post‑myocardial infarction prophylaxis in adult patients.

GNH India supplies Metoprolol Alvogen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Alvogen Ehf

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metoprolol Alvogen is a beta‑adrenergic blocker indicated for several cardiovascular conditions.
  • Hypertension: lowers systemic blood pressure and reduces cardiovascular risk.
  • Angina pectoris: decreases myocardial oxygen demand, relieving chest pain.
  • Chronic heart failure: improves ventricular function and reduces hospitalisation.
  • Post‑myocardial infarction prophylaxis: lowers the chance of recurrent cardiac events.

How It Works

  • Metoprolol succinate selectively antagonises β1‑adrenergic receptors in cardiac tissue, diminishing sympathetic stimulation. This reduces heart rate, myocardial contractility, and cardiac output, leading to lower blood pressure and decreased myocardial oxygen consumption, which underpins its antihypertensive, anti‑anginal, and heart‑failure benefits.

Side Effects

Metoprolol Alvogen may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Fatigue or tiredness
  • Dizziness or light‑headedness
  • Headache
  • Bradycardia (slow heart rate)
  • Cold extremities
  • Gastrointestinal upset (nausea, abdominal discomfort)

Serious or Rare Side Effects

  • Severe bradycardia or heart block
  • Marked hypotension
  • Bronchospasm, especially in patients with asthma or COPD
  • Allergic reactions (rash, angioedema)
  • Depression or mood changes
  • Worsening heart failure

Precautions & Warnings

  • Before initiating therapy, clinicians should consider several safety aspects.
  • Monitor blood pressure: ensure adequate control without excessive drop.
  • Assess heart rate: avoid use in patients with resting bradycardia.
  • Use caution in asthma/COPD: β1‑selectivity may still affect bronchial tone.
  • Adjust in renal/hepatic impairment: dose may need modification.
  • Avoid abrupt discontinuation: taper to prevent rebound tachycardia.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Metoprolol succinate can interact with a variety of medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Non‑selective beta blockers in severe asthma: risk of bronchospasm.
  • Other AV‑node blockers (verapamil, diltiazem): may cause profound bradycardia.
  • Clonidine withdrawal: can precipitate hypertension.
  • MAO inhibitors: may enhance hypotensive effect.
  • Potent CYP2D6 inhibitors (quinidine, paroxetine): increase metoprolol levels.

Moderate Interactions (Monitor Closely)

  • Diuretics: may amplify hypotensive response.
  • ACE inhibitors or ARBs: additive blood‑pressure lowering.
  • NSAIDs: may reduce antihypertensive effect.
  • Calcium‑channel blockers: monitor for bradycardia.
  • Antidiabetic agents: may mask hypoglycaemia symptoms.

Frequently Asked Questions

Metoprolol Alvogen contains metoprolol succinate, a beta‑adrenergic blocker indicated for the management of hypertension, angina pectoris, chronic heart failure, and for reducing the risk of recurrent events after a myocardial infarction in adult patients.

Metoprolol succinate selectively blocks β1‑adrenergic receptors in the heart, decreasing sympathetic stimulation. This leads to a slower heart rate, reduced contractile force, and lower cardiac output, which together lower blood pressure and myocardial oxygen demand.

Dosing is individualized based on the patient’s condition, response, and tolerability. The prescribing clinician determines the appropriate strength, frequency, and titration schedule according to current clinical guidelines.

Safety data are limited; the drug should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. Clinicians should discuss risks and alternatives with the patient.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Metoprolol succinate is a cardio‑selective (β1‑selective) agent, offering a lower risk of bronchospasm compared with non‑selective beta blockers such as propranolol. Its once‑daily extended‑release formulation provides steady plasma concentrations, which can improve adherence relative to short‑acting agents.

Store the tablets at room temperature, below 25 °C, in the original container to protect them from moisture and light. Keep out of reach of children and do not use if the packaging is damaged.

Metoprolol Alvogen is taken orally, usually as a whole tablet swallowed with water. It can be taken with or without food, but consistency with meals helps maintain stable absorption.

Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience these symptoms.

Metoprolol Alvogen is contraindicated in patients with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, uncompensated heart failure, and in those with severe asthma or COPD where β‑blockade could precipitate bronchospasm.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metoprolol Succinate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT